-
1
Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections
Published 2024-12-01Subjects: Get full text
Article -
2
National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for <i>Pseudomonas aeruginosa</i>
Published 2024-12-01Subjects: “…meropenem–vaborbactam…”
Get full text
Article -
3
Are New β-Lactam/β-Lactamase Inhibitor Combinations Promising Against Carbapenem-Resistant <i>K. pneumoniae</i> Isolates?
Published 2025-02-01Subjects: Get full text
Article -
4
Meropenem/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections
Published 2025-07-01Subjects: Get full text
Article